Opening Targeting Drug Tolerant Persister State in Lung Cancer (Yale Cancer Center Grand Rounds)
Targeting Drug Tolerant Persister State in Lung Cancer (Yale Cancer Center Grand Rounds)
- Length
- 59 min
- Level
- Research
- Recorded
- Yale University2024
Chapter 1 of 9: Before the lecture
Drug-tolerant persister cells explain why EGFR-mutant lung tumors shrink under targeted therapy yet survive until acquired resistance emerges. At Yale Cancer Center Grand Rounds, Jänne shows surviving cells upregulating YAP and TEAD signaling and the anti-apoptotic protein BCL-XL. Their senescent features point to BCL-XL inhibitors, combined with MEK inhibitors or carried by antibody-drug conjugates to EGFR-expressing cells to limit toxicity. RNA sequencing and on-treatment biopsies reveal enriched surface proteins such as TROP2, which TROP2-directed CAR T cells eradicate in preclinical models. FLAURA2 data and audience questions on resistance and normal-tissue toxicity close the seminar.

Your comment is kept while you sign up.Sign in
Jänne tracks EGFR-inhibited lung cancer cells into a senescent persister state and targets them through TROP2.
Drug-tolerant persister cells explain why EGFR-mutant lung tumors shrink under targeted therapy yet survive until acquired resistance emerges. At Yale Cancer Center Grand Rounds, Jänne shows surviving cells upregulating YAP and TEAD signaling and the anti-apoptotic protein BCL-XL. Their senescent features point to BCL-XL inhibitors, combined with MEK inhibitors or carried by antibody-drug conjugates to EGFR-expressing cells to limit toxicity. RNA sequencing and on-treatment biopsies reveal enriched surface proteins such as TROP2, which TROP2-directed CAR T cells eradicate in preclinical models. FLAURA2 data and audience questions on resistance and normal-tissue toxicity close the seminar.
Hata et al. Nature Medicine 2016
Oxnard Nature Medicine 2016
Tricker et al. 2015 Cancer Discovery
Kurppa et al. Cancer Cell 2020
Senolytics for Cancer Therapy: Is All That Glitters Really Gold?
TROPION-Lung05 Study
This lecture
Talk 21 of 26 of Yale Cancer Center Grand Rounds.
Choose a node to see how it connects to this lecture. What comes before is on the leftat the top. What comes after is on the rightat the bottom. The ring is what it teaches. People and places are above.
Press a chosen node again to open it.